Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|November 24, 2011
The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancerS B Villadsen, J B Bramsen, M S Ostenfeld, et al.
Plos One|December 2, 2011
MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinomaErik D Wiklund, Shan Gao, Toby Hulf, et al.
Physical Review Letters|August 2, 2024
Purifying Photon Indistinguishability through Quantum InterferenceCarlos F D Faurby, Lorenzo Carosini, Huan Cao, et al.
Radiography (London, England : 1995)|February 11, 2026
A retrospective comparison of image quality in T2-weighted paediatric brain MRI using Children- centred Care versus anaesthesiaK Brage, G B Villadsen, D S Heglingegård, et al.
Nutrients|October 14, 2023
Use of Fermented Red Clover Isoflavones in the Treatment of Overactive Bladder in Postmenopausal Women: A Randomized, Double-Blinded, Placebo-Controlled TrialAnnemarie B Villadsen, Julie N Holm-Jacobsen, Bala K Prabhala, et al.
International Journal of Cancer|May 18, 2010
Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancerErik D Wiklund, Jesper B Bramsen, Toby Hulf, et al.
The American Journal of Cardiology|July 8, 2019
Everolimus-Eluting Versus Biolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes MellitusChristine Gyldenkerne, Kevin K W Olesen, Lisette O Jensen, et al.
The New England Journal of Medicine|August 22, 2003
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarctionHenning R Andersen, Torsten T Nielsen, Klaus Rasmussen, et al.
Lancet (London, England)|March 18, 2014
Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trialMichael Maeng, Hans Henrik Tilsted, Lisette Okkels Jensen, et al.
JACC. Cardiovascular Interventions|August 25, 2012
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stentsMichael Maeng, Hans-Henrik Tilsted, Lisette Okkels Jensen, et al.
Pageof 3